Trial Profile
The TOMIBA study Treatment of Osteoporotic Men With Intravenous Ibandronate An open-label, single-center, prospective Phase III study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- Acronyms TOMIBA
- 29 Aug 2011 New trial record